Search results

Following a vote in the European Parliament on the EU budget for 2019, Oxfam is concerned that the EU continues to prioritize migration management at the expense of humanitarian action and sustainable development.

We've reviewed and analyzed the G8 Communique from Day 1 of the Summit, and here's our take.

To roll out his global health strategy, UN General Secretary Ban Ki Moon has announced today US$40 billion for all three health-related poverty goals, with a strong focus on women and chil

A one-off 99 percent levy on billionaires’ wealth gains during the pandemic could pay for everyone on Earth to be vaccinated against COVID-19 and provide a $20,000 cash grant to all unemployed workers, according to new analysis released today by Oxfam, the Fight Inequality Alliance, the Institute for Policy Studies and the Patriotic Millionaires.

In reaction to Pfizer’s announcement of voluntary licenses of its COVID-19 oral antiviral treatment Paxlovid to the Medicines Patent Pool, People’s Vaccine Alliance spokesperson and Oxfam America’s Senior Advocacy Advisor, Robbie Silverman, said: “Pfizer’s announcement to voluntarily licence the COVID treatment Paxlovid is welcome but is far from enough."     

An article in the British Medical Journal and Die Welt, published today, has found that the KenUP Foundation - acting as a consultant on behalf of BioNTech – has been pushing South African manufacturers not to get involved the World Health Organization Vaccine Technology Transfer Hub’s project of copying the manufacturing process of existing mRNA COVID-19 vaccines and have been calling for the project to be ‘terminated immediately’. 

In reaction to the newly announced $10.3 billion UN Humanitarian Response Plan (UNHRP) appeal, Oxfam’s Head of Humanitarian Campaigns and Advocacy, Fionna Smyth, said: “We welcome this boost to the UN Covid-19 humanitarian appeal. Millions of people around the world already struggling to cope with crises brought about by conflict, poverty and climate change, have been hit even harder now by the coronavirus pandemic which has also fuelled a hunger crisis. This funding is lifesaving and urgently needed, yet less than a quarter of the previous appeal had been met."     

The United States government last night moved to support a waiver of intellectual property protections of the Covid-19 vaccine. The People’s Vaccine Alliance has been campaigning to suspend Covid-19 intellectual property protections and has this reaction: This is the decision the world needed: by backing a waiver of intellectual property protections for Covid-19 vaccines the Biden Administration can increase the global supply of vaccines and deal a deathblow to the Covid-19 pandemic.

Oxfam India welcomes the US decision to back the waiver of intellectual property protections for COVID-19 vaccines.  

Vaccinating the poorest half of humanity —3.7 billion people— against coronavirus could cost less than what the ten biggest pharmaceutical companies make in four months, Oxfam said today.